<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on European Medicines Agency</title><link href="http://diabetesinfoandtreatment.com/topic/european-medicines-agency" rel="alternate"></link><id>http://diabetesinfoandtreatment.com/topic/european-medicines-agency</id><updated>2010-11-30T13:09:00Z</updated><entry><title>Benfluorex</title><link href="http://diabetesinfoandtreatment.com/prediabetes/benfluorex-4654181a" rel="alternate"></link><updated>2010-11-30T13:09:00Z</updated><author><name>Mahalo</name></author><id>tag:diabetesinfoandtreatment.com,2010-11-30:/prediabetes/benfluorex-4654181a/</id><summary type="html">...</summary><category term="Clinical Trials"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Prediabetes"></category><category term="European Union"></category><category term="European Medicines Agency"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>European agency says Avandia should be pulled</title><link href="http://diabetesinfoandtreatment.com/diabetes/european-agency-avandia-pulled-1558873a" rel="alternate"></link><updated>2010-09-23T09:16:50Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-09-23:/diabetes/european-agency-avandia-pulled-1558873a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="European Medicines Agency" href="/topic/European+Medicines+Agency" &gt;European Medicines Agency&lt;/a&gt; says diabetes drug &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt; should be pulled from market&lt;/div&gt;&lt;div&gt;&lt;p&gt;European Medicines Agency says diabetes drug Avandia should be pulled from market.&lt;/p&gt;&lt;p&gt;In a news briefing on Thursday, the agency said it would suspend its marketing authorizations for the controversial drug which is linked to heart attacks.&lt;/p&gt;&lt;p&gt;It said ...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Medicines Agency"></category><category term="Western Europe"></category><category term="Avandia"></category></entry><entry><title>Safety fear drug 'still prescribed'</title><link href="http://diabetesinfoandtreatment.com/diabetes/safety-fear-drug-prescribed-1395696a" rel="alternate"></link><updated>2010-09-12T02:51:12Z</updated><author><name>ThisIsLondon.co.uk</name></author><id>tag:diabetesinfoandtreatment.com,2010-09-12:/diabetes/safety-fear-drug-prescribed-1395696a/</id><summary type="html">...</summary><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 2 Diabetes"></category><category term="United Kingdom"></category><category term="GlaxoSmithKline plc"></category><category term="European Medicines Agency"></category><category term="University College London"></category><category term="Western Europe"></category><category term="BMJ Publishing Group Ltd."></category><category term="Avandia"></category><category term="University of Birmingham"></category><category term="Cardiovascular Medicine"></category><category term="Deborah Cohen"></category><category term="John Yudkin"></category><category term="Nick Freemantle"></category><category term="Commission on Human Medicines"></category></entry><entry><title>European agency to review safety of GSK's Avandia</title><link href="http://diabetesinfoandtreatment.com/diabetes/european-agency-review-safety-gsks-avandia-987156a" rel="alternate"></link><updated>2010-07-09T03:30:13Z</updated><author><name>AP News</name></author><id>tag:diabetesinfoandtreatment.com,2010-07-09:/diabetes/european-agency-review-safety-gsks-avandia-987156a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="European Medicines Agency" href="/topic/European+Medicines+Agency" &gt;European Medicines Agency&lt;/a&gt; to review safety of &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt;'s diabetes drug &lt;a title="Avandia" href="/topic/Avandia" &gt;Avandia&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;The European Medicines Agency says it will review the safety of the diabetes drug Avandia following research suggesting it is linked to a higher risk of heart problems, strokes and dea...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="GlaxoSmithKline plc"></category><category term="European Medicines Agency"></category><category term="Avandia"></category><category term="EMEA Committee for Medicinal Products for Human Use"></category></entry></feed>
